refreshing to see that for sure.
It's time that here in the US, the "P-Value" stands for the "Value of Patients' lives", not just the result of a trial that had a flawed design.
In fact, that tag-line should be the title of an editorial article in the NY Times, or the WSJ - feel free to borrow it and send it to someone. It's time for the public to know the truth about a drug that could've saved thousands of lives, but is being slowed down by the FDA.
News 
Market Data 
Discover 
